MULTIPLE sclerosis is now too urgent a problem for temporizing approaches. In this disease too many leads have remained unfollowed; too many answerable questions have evoked no enquiry.
I shall begin by referring to the report of Campbell et al. (1947) which has naturally received prominence in the world literature on demyelinating disease. It will be remembered that four out of seven research workers on swayback were thought to be affected by a disease indistinguishable from multiple sclerosis. Since over ten years have now elapsed, ample time would seem to have occurred for re-assessment of this report. In this instance some fresh information would seem to be a paramount scientific need. The clinically most typical case of the four was the only one known to me; this patient eventually succumbed to multiple sclerosis which-I think by a curious coincidence only-happened to be of a rather "transitional" type with diffuse cerebral demyelination and with plaques of the more typical discrete type only in the optic pathway, cerebellum, brain-stem and cord. I hope to report and illustrate the pathological findings in this case elsewhere in full detail. As far as I can ascertain this case was purely coincidental and has no relevance whatsoever to the swayback problem. If we were to learn that the diagnosis of multiple sclerosis is no longer tenable in the remaining cases cited in the 1947 report I think it would be of real value in the difficult field of multiple sclerosis research.
The suggestion of communicability implicit in the swayback report reminds us that the infection hypothesis is the oldest and still most widely favoured among neuropathologistsa view reiterated by Greenfield et al. (1958) . The Shubladze vaccine, too, has been the subject of recent lay and medical publicity (1958, Brit. med. J., i, 821) . Two facts call for re-emphasis:
(1) The Russian E.H.A. virus, strain Sv. ("encephalomyelite humaine aigue", from patient Sv.), used for the vaccine, was isolated from a case that would not be diagnosed as multiple sclerosis here (Margulis et al., 1946) ; and (2) the vaccine is a (rodent) brain suspension and, even though formolized, liable to produce allergic encephalitis in view of what we know of the experimental disease. The virus question is therefore still entirely open. Supporters of a virus etiology have criticized the earlier negative work on the grounds that a causative virus for multiple sclerosis might be human-specific as well as brain-specific. To investigate this an attempt was made to work out a tissue culture method using human nervous tissue, with neurons, neuroglia and cerebral mesoblastic cells, and taking fresh plaque material under aseptic conditions within the first few hours (Lumsden, 1957c) . The method came as closely as possible to satisfying technically the most stringent criticisms since it succeeded in recovering from the plaque tissues still-viable tissue cells which might reasonably be expected to act at least temporarily as vehicles, if not hosts, for the virus until the nerve fibres and neuroglia from the implanted normal tissue had had time to merge with the living cells and dead fragments from the plaque tissue under test (Fig. 1) . The results were completely negative in all plaques taken from the six cases of multiple sclerosis tested but are not considered as more than suggestive since no case of really florid "acute multiple sclerosis" was included. In the event of such a case occurring, the brain should be removed aseptically within three or four hours and fragments of 3-4 mm. diameter each, at the edges of fresh plaques, distributed in sterile bijou bottles and stored and transported in solid carbon dioxide-a method by no means ideal but the only practicable one where the culture facilities just outlined are not immediately available.
The foregoing method as carried out on fresh unfrozen tissue in these six cases served also to provide a reasonable method for culturing larger organisms like spirochetes. Steiner (1952) insists that, with careful search in acute plaques and by scrupulous attention to technical processing and staining, spirochaetes which are neither artifacts nor technical contaminants can be found in early acute lesions which are not found in control material or in older plaques. His long experience and advocacy of an unpopular doctrine against hostility commands serious attention. Using his method I found no stainable spirochetes in selected plaques from the same cases as were used for virus testing. We have also processed a certain amount of material from other cases the examination of which is still incomplete. But the critical condition for adequate refutation of Steiner's doctrine would be failure to find such spirochetes in all cases of fatal "acute multiple sclerosis". These cases should be freshly autopsied and selected plaques cut immediately and fixed in 10% formalin made with freshly distilled water. The processing can be done subsequently in any laboratory of neuropathology which will, no doubt, collaborate in this problem provided that the case is suitably selected and the material taken with stringent care. The microscopical scrutiny of such material is especially exacting and familiarity with such artifacts as those shown in Fig. 2 portions for Steiner's method is advisable since the real issue in Steiner's findings is whether the spirochktes in his cases may have been of sapraemic nature in moribund patients with extensive bedsores. In multiple sclerosis out-patient clinics, the recent claims of Ichelson (1957) to have isolated spirochites from C.S.F. by culture could presumably be tested stringently within, perhaps, a matter of twelve to eighteen months without too great an expense outlay. All these laboratory investigations seem to require to be repeated properly if the spirochite claims are to be adequately revaluated, since therapeutic trials with antibiotics are likely to be more difficult to assess, for reasons mentioned elsewhere (McAlpine, Compston and Lumsden, 1955). Experimentally, "allergic" encephalomyelitis is a contribution primarily to general pathology as much as to neurology since it is quantitatively the most striking example of a purely immunopathological process. Unfortunately, until specific antigens or antibodies are identified it is premature to talk of its "immunochemistry" since the refined quantitative methods of immunochemistry have not, and cannot, yet be brought to bear upon it. A relationship between experimental "allergic" ECM and human post-infectious encephalomyelitis has been postulated but there is as yet no scrap of laboratory evidence for this. In Leeds, with Perier and Marmion, I have this year begun to try to get some direct evidence for such a relationship (unpublished experiments). Cavy-passaged vaccinia virus has been used to produce skin vaccinia of different degrees of severity in guinea-pigs. Then, at different time intervals, affected skin has been removed and sterilized variously by autoclaving or by treatment with f-propiolactone or formalin, homogenized with adjuvants and injected (to date) into sixty test animals. This experiment has failed to produce allergic encephalomyelitis.
While efforts have begun to be made elsewhere to purify the components of the injection mass in the hope of isolating pure antigens and, with the use of complement fixation and skin sensitivity methods, to demonstrate the antibodies presumptively involved, next to nothing has been done towards understanding the pathogenesis of the structural lesions. An obvious postulate accounting for the special susceptibility of brain tissue to an immunopathological process is that it is somehow bound up with the blood-brain-barrier and the late development of myelin, resulting in a failure of acquired immunotolerance to myelin lipoprotein (Lumsden, 1957a) . There is some experimental support for this hypothesis (Paterson and Hansbrote, 1957) .
It has been too uncritically accepted that this is a "demyelinating" disease. My personal experience is based on four experimental species-guinea-pig, monkey, goat and rat-and from these as well as from the literature on the disease in other species I am unable to accept that "allergic" ECM is specifically demyelinating. The lesions are primarily vascular and, as illustrated earlier at this Society (Lumsden, 1956) , may or may not involve the parenchymatous tissue components. When most of the vessels in an area are affected confluent parenchymatous destruction may result, leading in myelin preparations to a pale area. In so far as axon destruction accompanies the demyelination and a state of spongiosis follows it can be said that some necrosis accompanies all lesions. Distinction between necrotizing and nonnecrotizing types of lesions seems to me to be false. Trypan blue studies show extensive perivascular oedema (own observations) so that this factor alone may play an important role in the secondary parenchymatous damage. Also, in view of what is now known of the pharmacology of the inflammatory response it would seem desirable, in this often excessively severe inflammatory process, to investigate whether histamine-like substances and pharmacologically active polypeptides or other "spreading factors" may be released from the mesoblastic cells in the vessel walls which are so profoundly stimulated in this process. Such "spreading factors" might be responsible for some aspects of the parenchymatous damage.
Whatever the pathogenesis of allergic encephalomyelitis, the fact is that no experimental instance has, to my knowledge, been published or illustrated which reproduces specifically demyelinating lesions in any way approaching the characteristic lesions of multiple sclerosis which I think it is important to re-examine regularly if one is to keep one's sense of perspective (Fig. 3) . Refuge has been taken by many in the postulate that the difference may be merely a species one: that man with experimental "allergic" ECM would get multiple sclerosis. In fact there is no evidence that human post-infectious ECM proceeds to multiple sclerosis (Lumsden, 1951) . Uchimura and Shiraki's (1957) cases, ostensibly of anti-rabic vaccinial ECM, have been cited as bridging the gap between the experimental allergic ECM and human multiple sclerosis on the argument that these multiple sclerosis-like lesions following antirabic vaccination have special significance in a country where multiple sclerosis is said to be extremely rare. But if we accept this reasoning then we are confronted with a very disturbing conclusion: viz. that multiple sclerosis can readily enough be reproduced in the brains of natives of Japan provided that an adequate exogenous cause is operative.
All the foregoing lines of investigation need to be carried through to conclusion without delay. It will be obvious, however, that I personally feel, for various reasons considered elsewhere (McAlpine et al., 1955) , that their solution will not answer the riddle of multiple sclerosis although they will clear the field and will therefore be enormously useful. In the end I feel we will be held up chiefly because we do not yet know enough about the biology of myelin. For instance, chemically there is evidence for a slow but constant metabolic turnover of myelin, and for a slow maturation from childhood to adulthood-the evidence for which has been considered elsewhere (Lumsden, 1957b) . These suggest at least two fundamental questions of possible immediate relevance to demyelinating disease: (a) what do we know of the structural stability of myelin, and (b) can sheaths regenerate in vivo provided the axoplasm is viable? These two questions, along with a third "Can sheaths be selectively affected in vitro?" are the sort of vital questions which I feel that we require urgently to answer and to which we have turned now in our laboratory using the methods of Peterson and Murray and of Hild on tissue culture of avian spinal ganglia and mammalian cerebellum during the time of myelination.
DISCUSSION
Dr. J. Olivier Perier (Pathology Department, University of Leeds)': In vitro formation of myelin in both the peripheral and central nervous systems, as reported respectively by Peterson and Murray (1955) and by Hild (1957), is sufficiently important in itself to warrant confirmation and study, theoretically affording a fairly simple experimental system for morphological and histochemical studies of myelinogenesis. But here we wish only to draw attention to three points which have direct implications for demyelinating diseases:
(1) The relation of myelin sheath formation to satellite cells.-Peterson and Murray, using avian spinal ganglia, find that myelination in vitro occurs only when the Schwann cells have come into close apposition with the nerve fibres, and serial photography shows that an actual wrapping or winding process is involved (Murray, 1957) . In such preparations the axon migrates out first as a non-myelinated fibre unaccompanied by Schwann cells. Subsequently, Schwann cells move into permanent apposition with the fibre. Myelination, however, occurs only sporadically and when it does occur it can be seen that it is de novo. On the other hand, with kitten and puppy cerebellum cultures, the myelin ( Fig. 1A and B ), which can be obtained more easily in our hands than in the Peterson-Murray preparation, occurs apparently in the area of spreading of the explant behind the fringe of migrating mesoblastic and glial cells, and bears no spatial relationship to glial cells. It is thus less clear in these conditions that the axons have migrated and that the myelin is new-formed. Hild concludes from his studies that it is new-formed myelin. We find that when myelin "reappears" after several weeks it 'British Council Fellow. Permanent address: Pathology Department, University of Brussels.
FIG. 1.-Myelin in vitro. Two myelinated segments of axons after forty days in vitro from a culture of a fragment of cerebellar folium of a 10-day-old kitten. In zone of neuroglial spread. The background fibres are mainly neuroglial but include many non-myelinated axons. Fixation by formol-Ringer. Stained with Sudan black B. x 1,300.
N.B.: In "A" the fibre shows a fusiform swelling of the myelin in the centre of which the axon can be seen. sometimes does so with such rapidity and so profusely distributed that it seems impossible that it can be pre-existing myelin which has been missed before.
(2) Selective demyelination in vitro.-Both in the Hild material and in the Peterson-Murray preparations with older embryos, many nerve fibres are already myelinated in vivo at the time of explantation. If these authors' findings are accepted then the possibility exists that in the conditions of culture, demyelination with axon survival and subsequent remyelination may be occurring. Since both of these possibilities are of such importance to the problem of multiple sclerosis, direct observational evidence on individual fibres will be necessary. While it seems beyond question that new myelin is formed in Peterson and Murray's cultures, the original state of the axons-whether they were originally myelinated or non-myelinatedstill calls for demonstration. In the Hild type of preparation we have not yet been able to decide whether the individual fibres that form myelin in vitro were originally non-myelinated, or whether they were myelinated fibres which lost their myelin at first in vitro and re-formed it later.
(3) Persistence of myelin in vitro.-In some parallel studies on human adult sympathetic ganglia, non-growing but still myelinated fibres can be observed projecting from the frayed edges of the explants. For as long as six weeks after explantation, myelin sheaths have been seen to retain their morphological characteristics including a strong birefringence. These nerve fibres never developed any signs of growth nor of any movements at the tips of their processes and so were evidently dead. Furthermore, being myelinated, they were presumptively pre-ganglionic and must therefore have been severed from their neurons of origin at the time of explanting. The only conclusion seems to be that with these more mature fibres in the conditions of culture the process of myelin breakdown is retarded or arrested compared with the normal situation in vivo. We are hoping this may afford us the opportunity of studying the stages of myelin degradation in vitro.
